Invasive lobular carcinoma of the breast has better short- and long-term survival than invasive ductal carcinoma
1997

Invasive Lobular Carcinoma vs. Invasive Ductal Carcinoma: Survival Comparison

Sample size: 1338 publication Evidence: high

Author Information

Author(s): S Toikkanen, L Pylkkanen, H Joensuu

Primary Institution: University Central Hospital of Turku

Hypothesis

Invasive lobular carcinoma (ILC) has better survival outcomes compared to invasive ductal carcinoma (IDC).

Conclusion

Women with invasive lobular carcinoma have better short- and long-term survival rates than those with invasive ductal carcinoma.

Supporting Evidence

  • ILC patients had lower rates of axillary nodal metastases compared to IDC patients (43% vs 53%).
  • 5- and 30-year corrected survival rates for ILC were 78% and 50%, respectively, compared to 63% and 37% for IDC.
  • ILCs were more frequently of low grade and had lower mitotic counts than IDCs.

Takeaway

This study found that women with a type of breast cancer called lobular carcinoma tend to live longer than those with ductal carcinoma.

Methodology

The study compared outcomes and prognostic factors of 217 women with invasive lobular carcinoma and 1121 women with invasive ductal carcinoma, following them for 10-43 years.

Limitations

The study is retrospective and may be limited by the accuracy of historical data and classification.

Participant Demographics

All participants were female patients diagnosed with invasive breast cancer in Turku, Finland.

Statistical Information

P-Value

P=0.001

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication